【EFPIA】Access to oncology combination therapies in Europe moving forward.pdf

Intra-Cellular Therapies Inc 2024年度报告

AK112 to validate its potential as next-generation IO therapy

Considerations for the use of anthelminthic therapy for the treatment of neurocysticercosis

Medical Rationale Supporting Patient Access To Novel Oncology Combination Therapies

BioRestorative Therapies Inc 2024年度报告